Redx Pharma Plc has won the coveted Deal of the Year award at the prestigious Bionow Awards for successfully raising £15 million listing on the London Stock Exchange’s (LSE) Alternative Investment Market (AIM) earlier this year.
The Bionow Awards recognise and celebrate excellence within the biomedical and life science sectors across Northern England, showcasing the very best of this world-class sector.
The company enjoyed a double win on the night, with Dr Peter Jackson, a non-executive director from Redx being recognised with Bionow’s Outstanding Contribution award.
The winners were announced at the prestigious Bionow Annual Awards Dinner on Thursday, November 26, which was attended by over 300 executives from across the biomedical industry.
Dr Neil Murray, Redx Pharma CEO, said: We’re delighted to have won this prestigious award and are grateful to the judges for recognising the vision, focus and effort which our team and advisers displayed — in particular our colleagues at Acceleris — and which culminated in successfully floating Redx Pharma on AIM in a difficult market. It was a pivotal moment for the business and we look forward to continuing to focus on growth and excellence through innovation.
The fact that Pete’s efforts and success have also been recognised with a well-deserved award on the night makes victory even sweeter and we’re delighted for him.